Arak H, Kuş T. Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy. Eur J Ther [Internet]. 2024 May 23 [cited 2024 Jun. 30];. Available from: https://eurjther.com/index.php/home/article/view/2151